Cann Group Limited (ASX:CAN)

Market Cap	9.58M -35.0%
Revenue (ttm)	11.31M -27.1%
Net Income	14.73M
EPS	0.02
Shares Out	1.60B
PE Ratio	0.29
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,812,641
Average Volume	2,675,420
Open	0.0060
Previous Close	0.0060
Day's Range	0.0060 - 0.0060
52-Week Range	0.0050 - 0.0330
Beta	0.01
RSI	42.83
Earnings Date	Feb 27, 2026

About Cann Group

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CAN

Financial Performance

In fiscal year 2025, Cann Group's revenue was 13.25 million, a decrease of -27.81% compared to the previous year's 18.36 million. Losses were -22.35 million, -56.39% less than in 2024.